SUNNYVALE, Calif. , July 31, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its fourth quarter and fiscal year 2012, ended June 30, 2012 on Thursday, September 6, 2012 after the market closes.
Accuray to Host an Educational Symposium Highlighting Enhanced Capabilities of Its CyberKnife and TomoTherapy Treatment Systems SUNNYVALE, Calif. , July 29, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that more than 70 studies
Acquisition Allows Accuray to Provide Leading-Edge Image Processing Software and Further its Mission to Deliver Personalized Treatment Solutions SUNNYVALE, Calif. , July 16, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that they
Image-Guided, Intensity Modulated Radiation Therapy Added to UCSF's Suite of Treatment Options for Cancer Patients SUNNYVALE, Calif. , June 27, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that doctors at the University of
Partnership Creates Strategic Alliance for Advancement of Research in Radiation Oncology in the Netherlands SUNNYVALE, Calif. , June 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and
CFO Presents Strategy to Deliver Growth and Vision for Future at Wells Fargo Healthcare Conference SUNNYVALE, Calif. , June 21, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the company's successes since its acquisition of
Company Strengthens its Commitment to the Japanese Market and to Supporting the Growth of the TomoTherapy® System Worldwide SUNNYVALE, Calif. , June 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the extension of its
SUNNYVALE, Calif. , June 13, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Wells Fargo Healthcare Conference in Boston on Wednesday June 20, 2012 at 9:00 a.m. EDT / 6:00 a.m.
Long Term Outcomes for Intermediate-Risk Prostate Cancer Patients SUNNYVALE, Calif. , June 7, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that outcome data on intermediate risk prostate cancer patients treated with CyberKnife®
SUNNYVALE, Calif. , May 30, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Jefferies Global Healthcare Conference in New York on Thursday, June 7, 2012 at 11:30 a.m. EDT / 8:30 a.m.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
